University of Colorado Cancer Center
Playback speed
10 seconds
Venetoclax Combinations in AML: Addition of Aza/Dec in Previously Untreated Patients, Improvemens & Expansions, Predicting Non-responders
By
University of Colorado Cancer Center
FEATURING
Daniel Pollyea
By
University of Colorado Cancer Center
FEATURING
Daniel Pollyea
75 views
May 27, 2021
Comments 0
Login to view comments.
Click here to Login
Oncology Grand Rounds